News release: Renishaw announces completion of clinical trial extension study (docx)

File size: 107 kB Language: English

News release:  Renishaw announces completion of clinical trial extension study

Global engineering technologies company, Renishaw, is pleased to announce that its award-winning neuroinfuse™ drug delivery device, the only platform currently to allow for repeated, intermitent infusions into the the parenchyma, has continued to safely and effectively deliver infusions as part of an extension to a first-in-human clinical trial of cerebral dopamine neurotrophic factor (CDNF).

This type of file requires a viewer, freely available from Microsoft

Latest videos - Neurological products

Latest items - Neurological products

Didn't find what you were looking for?

Tell us what you couldn’t find and we will do our best to help